← All indications
Common Cold
A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing.
Drugs by status
Approved for this indication (28)
- phenylephrine
- diphenhydramine
- dexchlorpheniramine maleate
- ibuprofen
- guaifenesin
- methylscopolamine bromide
- ephedrine
- ipratropium
- naproxen
- acetaminophen
- acetylsalicylic acid
- clemastine
- menthol
- camphor
- salicylamide
- dexbrompheniramine
- novedrine
- sodium chloride
- dextromethorphan
- pseudoephedrine
- triprolidine
- brompheniramine maleate
- naphazoline
- xylometazoline
- methamphetamine
- cyclopentamine
- Andrographis paniculata
- chlorothymol
Phase 4 trials (8)
Phase 3 trials (14)
Phase 2 trials (11)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (17)
Organization Involved with Phase 3 Indications (28)
- Meda
- Ache Laboratorios Farmaceuticos S.A.
- Chattem
- Brainfarma Industria Química e Farmacêutica S/A
- Hyben Vital ApS
- InQpharm Group
- POM Wonderful LLC
- Schwabe
- SocraTec R&D GmbH
- National Center for Complementary and Integrative Health (NCCIH)
- Federal University of Health Science of Porto Alegre
- Federal University of Rio Grande do Sul
- University of Washington
- Texas Heart Institute
- University of Milan
- University of Rochester
- Cardiff University
- Pesquisare Saude S/S Ltda
- Clinilive
- CTD Dor Clinica de Diagnostico e Terapia da Dor Ltda
- Hospital Nipo-Brasileiro
- Government of Russia
- University of Sao Paulo
- EMS S/A
- Office of Dietary Supplements (ODS)
- Techtrials Pesquisa e Tecnologia Ltda
- Pharmagenix
- Atlant Clinical Ltd.
Organization Involved with Phase 2 Indications (18)
- Atopix Therapeutics, Ltd.
- Beijing Da-an Bio-technology Co., Ltd.
- Probi AB
- Tasly Pharmaceuticals, Inc.
- The Dial Corporation
- Medical Research Council
- Umeå University
- University of London
- University of Kiel
- University of Virginia
- Umea University
- BioActor
- Hill Top Research
- TKL Research
- Clemson University
- European Commission
- Johnson and Johnson
- Imperial College London
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (23)
- DuPont
- AstraZeneca
- Danisco
- Inner Mongolia Yili Industrial Group Co., Ltd
- Xigo Health LLC
- Kyberg Vital GmbH
- Green Beat
- Medical University of Graz
- University of South Florida
- Capital Medical University
- Jiao Tong University
- University of Ljubljana
- Beijing Institute of Otolaryngology
- Winthrop University
- NECCR/ IMCA LLC
- Embria Health Sciences
- Cargill
- People's Liberation Army of China
- Pusan National University
- The University of Texas, Dallas
- PharmaLinea d.o.o.
- Diagnostic Laboratory Medicare PLUS d.o.o.
- Clinres Farmacija d.o.o.